Statements (48)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
gptkb:CSL_Behring_Gmb_H
gptkb:Talecris_Biotherapeutics |
| gptkbp:awards |
various industry recognitions
|
| gptkbp:clinical_trial |
ongoing for new therapies
|
| gptkbp:community_involvement |
support for patient advocacy groups
sponsorship of health initiatives |
| gptkbp:employees |
over 25,000
|
| gptkbp:focus_area |
genetic disorders
neurology autoimmune diseases hematology critical care infectious diseases immunology transplantation pulmonology |
| gptkbp:founded |
1904
|
| gptkbp:headquarters |
gptkb:King_of_Prussia,_Pennsylvania,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
CSL Behring
|
| gptkbp:operates_in |
over 60 countries
|
| gptkbp:parent_company |
gptkb:CSL_Limited
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:production_location |
multiple locations worldwide
|
| gptkbp:products |
gptkb:vaccine
albumin coagulation factor concentrates |
| gptkbp:regulatory_compliance |
FDA approved products
EMA approved products |
| gptkbp:research_and_development |
focus on rare diseases
|
| gptkbp:specializes_in |
plasma-derived therapies
|
| gptkbp:sustainability_initiatives |
community health programs
energy efficiency measures water conservation efforts carbon footprint reduction ethical sourcing practices supply chain sustainability waste reduction strategies healthcare access initiatives community engagement projects employee engagement programs environmental responsibility programs research funding for public health |
| gptkbp:website |
www.cslbehring.com
|
| gptkbp:bfsParent |
gptkb:CSL_Limited
gptkb:Berinert gptkb:Haegarda |
| gptkbp:bfsLayer |
6
|